NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline SYPR Q3 2025 Earnings Return to Profitability with EPS of 002 Diageo DEO Q1 2026 Earnings EPS Misses Estimates as Spirits Demand Softens Globally PRLD Q1 2026 Earnings Narrower Loss Than Anticipated as Clinical Pipeline Advances NKSH Q4 2025 Earnings Earnings Surprise of 2111 Driven by Strong Operating Performance NMCO Edges Higher as Nuveen Municipal Credit Fund Holds Above Support Caseys General Stores CASY Slips 178 as Retail Sector Headwinds Linger SSACW Warrant Surges 14 MicroCap Speculative Move at 008 Support Scage Future SCAG Slides 4 Nears Critical Support at 047 GDOT Q1 2026 Earnings EPS Surges Past Estimates by 243